Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Vera Therapeutics, Inc. market cap for the quarter ending 2026-07-29 was $2.34B, a 74.19% increase year-over-year.
Vera Therapeutics, Inc. market cap for the quarter ending 2026-05-01 was $2.53B, a 66.73% increase year-over-year.
Vera Therapeutics, Inc. market cap for the quarter ending 2025-10-30 was $1.89B, a 37.29% decline year-over-year.
Vera Therapeutics, Inc. market cap for the quarter ending 2025-07-30 was $1.35B, a 31.84% decline year-over-year.
Vera Therapeutics, Inc. market cap for fiscal 2026 was $2.34B.
Vera Therapeutics, Inc. market cap for fiscal 2025 was $1.89B, a 37.29% decline from fiscal 2024.
Vera Therapeutics, Inc. market cap for fiscal 2024 was $3.02B, a 517.99% increase from fiscal 2023.
Vera Therapeutics, Inc. market cap for fiscal 2023 was $488.76M, a 5.06% increase from fiscal 2022.